This statistic is based on a survey conducted during the 2nd quarter of 2015. It describes major obstacles for developing personalized medicines according to pharmaceutical companies in Asia, Europe, and in the United States. Most of respondents stated that the lack of a regulatory guidance would be the major obstacle for developing personalized medicines.
Major obstacles for developing personalized medicines according to pharmaceutical companies worldwide as of 2015
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Reed Smith. (November 9, 2015). Major obstacles for developing personalized medicines according to pharmaceutical companies worldwide as of 2015 [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/727253/top-obstacles-for-personalized-medicine-as-to-pharma-companies/
Reed Smith. "Major obstacles for developing personalized medicines according to pharmaceutical companies worldwide as of 2015." Chart. November 9, 2015. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/727253/top-obstacles-for-personalized-medicine-as-to-pharma-companies/
Reed Smith. (2015). Major obstacles for developing personalized medicines according to pharmaceutical companies worldwide as of 2015. Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/727253/top-obstacles-for-personalized-medicine-as-to-pharma-companies/
Reed Smith. "Major Obstacles for Developing Personalized Medicines According to Pharmaceutical Companies Worldwide as of 2015." Statista, Statista Inc., 9 Nov 2015, https://www.statista.com/statistics/727253/top-obstacles-for-personalized-medicine-as-to-pharma-companies/
Reed Smith, Major obstacles for developing personalized medicines according to pharmaceutical companies worldwide as of 2015 Statista, https://www.statista.com/statistics/727253/top-obstacles-for-personalized-medicine-as-to-pharma-companies/ (last visited November 21, 2024)
Major obstacles for developing personalized medicines according to pharmaceutical companies worldwide as of 2015 [Graph], Reed Smith, November 9, 2015. [Online]. Available: https://www.statista.com/statistics/727253/top-obstacles-for-personalized-medicine-as-to-pharma-companies/
